Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Ardent Health Partners (NYSE:ARDT) and maintained a price target of $24.
September 19, 2024 | 3:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Ardent Health Partners (NYSE:ARDT) and maintained a price target of $24.
The reiteration of an Overweight rating and a maintained price target of $24 by a reputable analyst can positively influence investor sentiment and potentially lead to a short-term increase in ARDT's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100